{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:04:40Z","timestamp":1765040680470},"reference-count":67,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beha.2016.08.029","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T08:15:44Z","timestamp":1478247344000},"page":"131-138","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Transformation of marginal zone lymphoma (and association with other lymphomas)"],"prefix":"10.1016","volume":"30","author":[{"given":"Carla","family":"Casulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.beha.2016.08.029_bib1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The non-Hodgkin's lymphoma classification project","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410","article-title":"The gastric marginal zone B-cell lymphoma of MALT type","volume":"96","author":"Zucca","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","article-title":"Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases","volume":"132","author":"Salama","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.beha.2016.08.029_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjh.12011","article-title":"Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases","volume":"159","author":"Montalb\u00e1n","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/annonc\/mdt507","article-title":"Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma","volume":"25","author":"Meyer","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"issue":"11","key":"10.1016\/j.beha.2016.08.029_bib8","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomasdagger","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.beha.2016.08.029_bib10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","article-title":"Transformation of indolent B-cell lymphomas","volume":"29","author":"Montoto","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2016.08.029_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","article-title":"Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review","volume":"98","author":"van den Brand","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2016.08.029_bib12","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"8","key":"10.1016\/j.beha.2016.08.029_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","article-title":"Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project","volume":"17","author":"Nathwani","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2016.08.029_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.5858\/2010-0741-LER","article-title":"Nodal marginal zone lymphoma with increased large cells: myth versus entity","volume":"135","author":"Kaur","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.beha.2016.08.029_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.beha.2016.08.029_bib16","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2016.08.029_bib17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cncr.22121","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience","volume":"107","author":"Tsimberidou","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-4608(02)00724-0","article-title":"Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones","volume":"141","author":"Heintel","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.beha.2016.08.029_bib19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.2008.07301.x","article-title":"High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis","volume":"143","author":"Dungarwalla","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.beha.2016.08.029_bib21","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2016.08.029_bib22","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3109\/10428194.2014.897703","article-title":"Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group","volume":"55","author":"Kalpadakis","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.beha.2016.08.029_bib23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.13320","article-title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","volume":"169","author":"Xing","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.2830450107","article-title":"Splenic lymphoma with circulating villous lymphocytes: report of seven cases and review of the literature","volume":"45","author":"Sun","year":"1994","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.beha.2016.08.029_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bjh.12036","article-title":"Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma","volume":"159","author":"Else","year":"2012","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.beha.2016.08.029_bib26","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2016.08.029_bib27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.beha.2016.08.029_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"18","key":"10.1016\/j.beha.2016.08.029_bib29","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"12","key":"10.1016\/j.beha.2016.08.029_bib30","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.beha.2016.08.029_bib31","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2015-12-624296","article-title":"Optimizing therapy for nodal marginal zone lymphoma","volume":"127","author":"Thieblemont","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2016.08.029_bib32","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3109\/10428194.2015.1106535","article-title":"Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation","volume":"57","author":"van den Brand","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"33","key":"10.1016\/j.beha.2016.08.029_bib33","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","article-title":"Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis","volume":"24","author":"Ghesqui\u00e8res","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2016.08.029_bib34","series-title":"The coding genome of nodal marginal zone lymphoma reveals recurrent molecular alterations of PTPRD and other Jak\/Stat signaling genes","author":"Spina","year":"2014"},{"issue":"3","key":"10.1016\/j.beha.2016.08.029_bib35","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1182\/blood-2011-02-339556","article-title":"Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets","volume":"119","author":"Arribas","year":"2012","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.beha.2016.08.029_bib36","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","article-title":"The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance","volume":"127","author":"Zucca","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2016.08.029_bib37","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2016.08.029_bib38","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V74.5.1796.1796","article-title":"Four new recurring translocations in non-Hodgkin lymphoma","volume":"74","author":"Levine","year":"1989","journal-title":"Blood"},{"issue":"9249","key":"10.1016\/j.beha.2016.08.029_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","article-title":"Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy","volume":"357","author":"Liu","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.beha.2016.08.029_bib40","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","article-title":"T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10","volume":"98","author":"Liu","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2016.08.029_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/(SICI)1096-9896(199808)185:4<409::AID-PATH121>3.0.CO;2-T","article-title":"High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas","volume":"185","author":"Peng","year":"1998","journal-title":"J Pathol"},{"issue":"16","key":"10.1016\/j.beha.2016.08.029_bib42","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1200\/JCO.2006.05.6150","article-title":"Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma","volume":"24","author":"Sagaert","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2016.08.029_bib43","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.leu.2404244","article-title":"Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation","volume":"20","author":"Haralambieva","year":"2006","journal-title":"Leuk Off J Leuk Soc Am Leuk Res Fund UK"},{"issue":"4","key":"10.1016\/j.beha.2016.08.029_bib44","first-page":"652","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leuk Off J Leuk Soc Am Leuk Res Fund UK"},{"issue":"9","key":"10.1016\/j.beha.2016.08.029_bib45","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1182\/blood-2004-03-1209","article-title":"Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome","volume":"104","author":"Barrans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood-2003-09-3103","article-title":"Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas","volume":"104","author":"Trentin","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib47","first-page":"182","article-title":"Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma","volume":"26","author":"Deutsch","year":"2013","journal-title":"Mod Pathol Off J U. S Can Acad Pathol Inc"},{"key":"10.1016\/j.beha.2016.08.029_bib48","article-title":"Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies","author":"Cani","year":"2016","journal-title":"Mod Pathol Off J U. S Can Acad Pathol Inc"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.20499","article-title":"TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma","volume":"47","author":"Honma","year":"2008","journal-title":"Genes Chromosom Cancer"},{"key":"10.1016\/j.beha.2016.08.029_bib50","doi-asserted-by":"crossref","first-page":"102656","DOI":"10.1155\/2015\/102656","article-title":"Molecular pathogenesis of MALT lymphoma","volume":"2015","author":"Troppan","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.beha.2016.08.029_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DAD.0b013e31804795a6","article-title":"Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH\/BCL2 and the t(14;18)(q32;q21) IGH\/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?","volume":"29","author":"Palmedo","year":"2007","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"10.1016\/j.beha.2016.08.029_bib52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1440-1827.2010.02554.x","article-title":"Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein-Barr virus infection: a case report","volume":"60","author":"Oka","year":"2010","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/adpa.2002.30611","article-title":"Hodgkin-like transformation of a marginal zone B-cell lymphoma of the larynx","volume":"6","author":"Fung","year":"2002","journal-title":"Ann Diagn Pathol"},{"issue":"10","key":"10.1016\/j.beha.2016.08.029_bib54","first-page":"1020","article-title":"Hodgkin's disease and an extranodal marginal zone B-cell lymphoma in the small intestine: an unusual composite lymphoma","volume":"9","author":"Aguilera","year":"1996","journal-title":"Mod Pathol Off J U. S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1066896911417242","article-title":"Concurrent gastric MALT and Hodgkin lymphoma: a case report","volume":"20","author":"Oka","year":"2012","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.beha.2016.08.029_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2257.2006.00859.x","article-title":"Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma \u2013 an unusual combination","volume":"29","author":"Elmahy","year":"2007","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2005.02046.x","article-title":"Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases","volume":"46","author":"Zettl","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2016.08.029_bib58","series-title":"Relationship between Hodgkin's disease and non-Hodgkin's lymphoma","author":"Jaffe","year":"1999"},{"key":"10.1016\/j.beha.2016.08.029_bib59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1752-1947-5-476","article-title":"Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report","volume":"5","author":"Carulli","year":"2011","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.beha.2016.08.029_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.humpath.2006.08.023","article-title":"Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones","volume":"38","author":"Lefebvre","year":"2007","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.beha.2016.08.029_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergencyto.2006.06.018","article-title":"Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders","volume":"171","author":"Rodig","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1016\/j.beha.2016.08.029_bib62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MEG.0b013e3282f4b238","article-title":"Composite marginal zone B cell lymphoma and enteropathy-type T cell lymphoma of the stomach: a case report","volume":"20","author":"Yun","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.beha.2016.08.029_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1066896909332454","article-title":"Composite biclonal marginal zone lymphoma of lung and chronic lymphocytic leukemia: pathologic, phenotypic, cytogenetic, and molecular study","volume":"19","author":"Bhagavathi","year":"2011","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"10.1016\/j.beha.2016.08.029_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00019606-200406000-00003","article-title":"A common clonal origin of nodal marginal zone B-cell lymphoma and plasma cell myeloma demonstrating different immunophenotypes: a case report of composite lymphoma","volume":"13","author":"Saito","year":"2004","journal-title":"Diagn Mol Pathol Am J Surg Pathol Part B"},{"issue":"8","key":"10.1016\/j.beha.2016.08.029_bib65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1440-1827.2003.01506.x","article-title":"Discordant lymphoma: MALT lymphoma of the stomach and follicular lymphoma of the parotid gland","volume":"53","author":"Yamamoto","year":"2003","journal-title":"Pathol Int"},{"issue":"10","key":"10.1016\/j.beha.2016.08.029_bib66","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"Kuppers","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2016.08.029_bib67","article-title":"Dual institution experience of nodal marginal zone lymphoma reveals excellent long- outcomes in the rituximab era","author":"Starr","year":"2016","journal-title":"Br J Haematol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T03:52:18Z","timestamp":1601178738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":67,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521692616300834"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.029","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transformation of marginal zone lymphoma (and association with other lymphomas)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}